Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Clinical Cohort Study of Pneumonia in Respiratory Intensive Care Unit

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02738645
Recruitment Status : Recruiting
First Posted : April 14, 2016
Last Update Posted : March 30, 2021
Sponsor:
Information provided by (Responsible Party):
Xiao Tang, Beijing Chao Yang Hospital

Brief Summary:
From 2003 when Severe Acute Respiratory Syndromes (SARS) appeared,many new types of respiratory viruses emerge in endlessly. Therefore, the epidemiology and the clinical character has changed quietly, especially severe pneumonia. This cohort study aim to obtain the contents of severe pneumonia patients in Respiratory Intensive Care Unit (RICU). Through the clinical data analysis, the investigators could get the information of the pneumonia caused by different reasons, such as morbidity and mortality, risk factors, clinical symptoms and radiographic changes, the respiratory support parameter and so on. The investigators hope the result could guide them do the clinical work of severe pneumonia better in the future.

Condition or disease Intervention/treatment
Pneumonia Other: pneumonia

Layout table for study information
Study Type : Observational
Estimated Enrollment : 800 participants
Observational Model: Cohort
Time Perspective: Other
Official Title: A Clinical Cohort Study of Pneumonia in Respiratory Intensive Care Unit
Study Start Date : June 2016
Estimated Primary Completion Date : December 2022
Estimated Study Completion Date : December 2022

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Pneumonia

Group/Cohort Intervention/treatment
pneumonia in RICU
The patients admit in RICU because of pneumonia.
Other: pneumonia



Primary Outcome Measures :
  1. the mortality caused by any reasons in RICU [ Time Frame: one years ]
  2. the morbidity caused by any reasons in RICU [ Time Frame: one years ]

Secondary Outcome Measures :
  1. the symptoms description of pneumonia caused by any reasons in RICU [ Time Frame: the first 48hours after admitted in RICU ]
    all the symptoms caused by pneumonia, such as fever, cough, dyspnea, sputum and so on. The investigators could get the incidence of each of these symptoms.

  2. the respiratory support of pneumonia caused by any reasons in RICU [ Time Frame: the first 5 days after admitted in RICU ]
    summarize the respiratory support parameters while the patients hospitalized in RICU. For example, the ventilation parameter and mode, Whether the mechanical ventilation complications occurred, and so on.

  3. the treatment options of pneumonia caused by any reasons in RICU [ Time Frame: 3 weeks ]
    the investigators obtain the treatment commons, such as the kind of antibiotics, the dosage of glucocorticoids, etc.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
the patients of RICU
Criteria

Inclusion Criteria:

  • admit in RICU because of pneumonia of any causes
  • anticipated length of hospital stay more than 72h

Exclusion Criteria:

  • admit in RICU because of other causes except pneumonia
  • do not agree to join this study
  • admit in RICU for the second time
  • anticipated length of hospital stay less than 72h

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02738645


Contacts
Layout table for location contacts
Contact: Bing Sun, Dr 86013911151075 ricusunbing@126.com
Contact: Xiao Tang, Dr 86013811089795 tangxiao0928@163.com

Locations
Layout table for location information
China, Beijing
Department of respiratory and critical care medicine,Beijing Chao-yang Hospital Recruiting
Beijing, Beijing, China, 100020
Contact: Bing Sun, MD    86013911151075    ricusunbing@126.com   
Contact: Xiao Tang, MD    86013811089795    tangxiao0928@163.com   
Principal Investigator: Bing Sun, MD         
Sponsors and Collaborators
Beijing Chao Yang Hospital
Investigators
Layout table for investigator information
Principal Investigator: Bing Sun, Dr Beijing Chao-Yang Hospital, China
Layout table for additonal information
Responsible Party: Xiao Tang, Dr, Beijing Chao Yang Hospital
ClinicalTrials.gov Identifier: NCT02738645    
Other Study ID Numbers: Pneumonia RICU
First Posted: April 14, 2016    Key Record Dates
Last Update Posted: March 30, 2021
Last Verified: March 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided
Additional relevant MeSH terms:
Layout table for MeSH terms
Pneumonia
Respiratory Tract Infections
Infections
Lung Diseases
Respiratory Tract Diseases